Ad is loading...
RCGHX
Price
$16.39
Change
-$0.38 (-2.27%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

RCGHX vs VGHCX

Header iconRCGHX vs VGHCX Comparison
Open Charts RCGHX vs VGHCXBanner chart's image
Virtus KAR Health Sciences C
Price$16.39
Change-$0.38 (-2.27%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
RCGHX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RCGHX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCGHX is a Sell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. RCGHX (127M). VGHCX pays higher dividends than RCGHX: VGHCX (0.79) vs RCGHX (0.00). RCGHX was incepted earlier than VGHCX: RCGHX (23 years) vs VGHCX (41 years). RCGHX is a more actively managed with annual turnover of: 75.00 vs. VGHCX (16.00). RCGHX has a lower initial minimum investment than VGHCX: RCGHX (2500) vs VGHCX (3000). RCGHX annual gain was more profitable for investors over the last year : 7.40 vs. VGHCX (1.65). VGHCX return over 5 years is better than : -2.73 vs. RCGHX (-36.52).
RCGHXVGHCXRCGHX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years41 years-
Gain YTD-1.384-2.20563%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets127M45.7B0%
Annual Yield % from dividends0.000.79-
Returns for 1 year7.401.65450%
Returns for 3 years-42.27-13.85305%
Returns for 5 years-36.52-2.731,340%
Returns for 10 years-49.44-9.94497%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen